Sandeep Laumas - Net Worth and Insider Trading

Sandeep Laumas Net Worth

The estimated net worth of Sandeep Laumas is at least $4 dollars as of 2024-06-06. Sandeep Laumas is the CEO, Executive Chairman of 9 Meters Biopharma Inc and owns about 38,819 shares of 9 Meters Biopharma Inc (NMTRQ) stock worth over $4. Details can be seen in Sandeep Laumas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sandeep Laumas has not made any transactions after 2019-06-28 and currently still holds the listed stock(s).

Transaction Summary of Sandeep Laumas

To

Sandeep Laumas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sandeep Laumas owns 5 companies in total, including 9 Meters Biopharma Inc (NMTRQ) , BioXcel Therapeutics Inc (BTAI) , and Unicycive Therapeutics Inc (UNCY) among others .

Click here to see the complete history of Sandeep Laumas’s form 4 insider trades.

Insider Ownership Summary of Sandeep Laumas

Ticker Comapny Transaction Date Type of Owner
NMTRQ 9 Meters Biopharma Inc 2019-06-28 director & Executive Chairman
BTAI BioXcel Therapeutics Inc 2018-03-07 director
UNCY Unicycive Therapeutics Inc 2023-09-05 director
LIMIT LIMIT 2021-03-18 CFO and CBO
LIMIT LIMIT 2022-01-11 10 percent owner

Sandeep Laumas Latest Holdings Summary

Sandeep Laumas currently owns a total of 1 stock. Sandeep Laumas owns 38,819 shares of 9 Meters Biopharma Inc (NMTRQ) as of June 28, 2019, with a value of $4.

Latest Holdings of Sandeep Laumas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
NMTRQ 9 Meters Biopharma Inc 2019-06-28 38,819 0.00 4

Holding Weightings of Sandeep Laumas


Sandeep Laumas Form 4 Trading Tracker

According to the SEC Form 4 filings, Sandeep Laumas has made a total of 2 transactions in 9 Meters Biopharma Inc (NMTRQ) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in 9 Meters Biopharma Inc is the acquisition of 200 shares on June 28, 2019, which cost Sandeep Laumas around $4,600.

Insider Trading History of Sandeep Laumas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sandeep Laumas Trading Performance

GuruFocus tracks the stock performance after each of Sandeep Laumas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sandeep Laumas is -33.35%. GuruFocus also compares Sandeep Laumas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sandeep Laumas within 3 months outperforms 0 times out of 9 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Sandeep Laumas's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Sandeep Laumas

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 9 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 5.66 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.41 LIMIT LIMIT LIMIT LIMIT LIMIT

Sandeep Laumas Ownership Network

Ownership Network List of Sandeep Laumas

No Data

Ownership Network Relation of Sandeep Laumas

Insider Network Chart

Sandeep Laumas Owned Company Details

What does 9 Meters Biopharma Inc do?

Who are the key executives at 9 Meters Biopharma Inc?

Sandeep Laumas is the director & Executive Chairman of 9 Meters Biopharma Inc. Other key executives at 9 Meters Biopharma Inc include Chief Financial Officer Bethany Sensenig , director & Chief Executive Officer John Temperato , and Chief Financial Officer Edward J Sitar .

9 Meters Biopharma Inc (NMTRQ) Insider Trades Summary

Over the past 18 months, Sandeep Laumas made no insider transaction in 9 Meters Biopharma Inc (NMTRQ). Other recent insider transactions involving 9 Meters Biopharma Inc (NMTRQ) include a net sale of 9,100 shares made by Bethany Sensenig ,

In summary, during the past 3 months, insiders sold 0 shares of 9 Meters Biopharma Inc (NMTRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,100 shares of 9 Meters Biopharma Inc (NMTRQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,100 shares.

9 Meters Biopharma Inc (NMTRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

9 Meters Biopharma Inc Insider Transactions

No Available Data

Sandeep Laumas Mailing Address

Above is the net worth, insider trading, and ownership report for Sandeep Laumas. You might contact Sandeep Laumas via mailing address: 8480 Honeycutt Rd, Suite 200, Raleigh Nc 27615.

Discussions on Sandeep Laumas

No discussions yet.